Global Benign Prostatic Hyperplasia Testing Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 116 pages | ID: G50B9F515A9GEN
GlobalInfoResearch

Abstracts

Benign prostatic hyperplasia (BPH) is a condition occurring in men when the prostate gland is enlarged. Benign prostatic hyperplasia is also termed as benign prostatic hypertrophy or benign prostatic obstruction. Prostate gland grows in primarily two phases, firstly during puberty when the size of the prostate doubles and the second growth phase starts at 25 years and continues throughout the lifetime. While the prostate gland enlarges in a man, it presses and pinches the urethra making the bladder wall thick. This pressure and squeeze on the urethra weaken the bladder and makes it lose the ability to empty the urine completely. Urinary retention and narrowing of the urethra can cause many problems which are associated with benign prostatic hyperplasia. Benign prostatic hyperplasia is one of the common prostate problems for men older than age 50.

SCOPE OF THE REPORT:

This report studies the Benign Prostatic Hyperplasia Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Benign Prostatic Hyperplasia Testing market by product type and applications/end industries.
Benign prostatic hyperplasia testing market is primarily driven by a few key factors such as the growing geriatric male population, patient awareness regarding rising healthcare concerns, increase in healthcare expenditure, increasing government initiatives and availability of minimally invasive surgery as a drug replacement, faster and easy performing diagnosis test results. The market is likely to grow owing to the novel diagnostic methods which are accurate than the conventional PSA blood test for benign prostatic hyperplasia which is effective in diagnosis and is expected to fuel the growth of benign prostatic hyperplasia testing market.
However, faces various challenges such as researchers which have found new ways to prevent the disease. Benign prostatic hyperplasia testing market tests are still in the primary stages of development which is a major restraint for the market. Benign Prostatic Hyperplasia Testing Market faces tremendous challenges due to the low awareness regarding the various diseases and diagnostic measures. Low-income countries and rising economies are coming forward to address such issues for benign prostatic hyperplasia testing market.
The global Benign Prostatic Hyperplasia Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Benign Prostatic Hyperplasia Testing.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• AEternaZentaris
• Astellas Pharma
• Eli Lilly and Company
• IntelGenx Technologies Corp
• Nymox Pharmaceutical Corporation
• Protox Therapeutics
• Quest PharmaTech

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Urinalysis
• Prostate-Specific Antigen (PSA) Blood Test
• Urodynamic Test
• Cystoscopy

Market Segment by Applications, can be divided into

• Hospitals
• Diagnostic Centers
• Clinics
• Research Institutes

Contents

1 BENIGN PROSTATIC HYPERPLASIA TESTING MARKET OVERVIEW

1.1 Product Overview and Scope of Benign Prostatic Hyperplasia Testing
1.2 Classification of Benign Prostatic Hyperplasia Testing by Types
  1.2.1 Global Benign Prostatic Hyperplasia Testing Revenue Comparison by Types (2017-2023)
  1.2.2 Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Types in 2017
  1.2.3 Urinalysis
  1.2.4 Prostate-Specific Antigen (PSA) Blood Test
  1.2.5 Urodynamic Test
  1.2.6 Cystoscopy
1.3 Global Benign Prostatic Hyperplasia Testing Market by Application
  1.3.1 Global Benign Prostatic Hyperplasia Testing Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Diagnostic Centers
  1.3.4 Clinics
  1.3.5 Research Institutes
1.4 Global Benign Prostatic Hyperplasia Testing Market by Regions
  1.4.1 Global Benign Prostatic Hyperplasia Testing Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Benign Prostatic Hyperplasia Testing Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Benign Prostatic Hyperplasia Testing Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Benign Prostatic Hyperplasia Testing Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Benign Prostatic Hyperplasia Testing Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Benign Prostatic Hyperplasia Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Benign Prostatic Hyperplasia Testing (2013-2023)

2 MANUFACTURERS PROFILES

2.1 AEternaZentaris
  2.1.1 Business Overview
  2.1.2 Benign Prostatic Hyperplasia Testing Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 AEternaZentaris Benign Prostatic Hyperplasia Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Astellas Pharma
  2.2.1 Business Overview
  2.2.2 Benign Prostatic Hyperplasia Testing Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Astellas Pharma Benign Prostatic Hyperplasia Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Eli Lilly and Company
  2.3.1 Business Overview
  2.3.2 Benign Prostatic Hyperplasia Testing Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Eli Lilly and Company Benign Prostatic Hyperplasia Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 IntelGenx Technologies Corp
  2.4.1 Business Overview
  2.4.2 Benign Prostatic Hyperplasia Testing Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 IntelGenx Technologies Corp Benign Prostatic Hyperplasia Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Nymox Pharmaceutical Corporation
  2.5.1 Business Overview
  2.5.2 Benign Prostatic Hyperplasia Testing Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Nymox Pharmaceutical Corporation Benign Prostatic Hyperplasia Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Protox Therapeutics
  2.6.1 Business Overview
  2.6.2 Benign Prostatic Hyperplasia Testing Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Protox Therapeutics Benign Prostatic Hyperplasia Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Quest PharmaTech
  2.7.1 Business Overview
  2.7.2 Benign Prostatic Hyperplasia Testing Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Quest PharmaTech Benign Prostatic Hyperplasia Testing Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL BENIGN PROSTATIC HYPERPLASIA TESTING MARKET COMPETITION, BY PLAYERS

3.1 Global Benign Prostatic Hyperplasia Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Benign Prostatic Hyperplasia Testing Players Market Share
  3.2.2 Top 10 Benign Prostatic Hyperplasia Testing Players Market Share
3.3 Market Competition Trend

4 GLOBAL BENIGN PROSTATIC HYPERPLASIA TESTING MARKET SIZE BY REGIONS

4.1 Global Benign Prostatic Hyperplasia Testing Revenue and Market Share by Regions
4.2 North America Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
4.5 South America Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA BENIGN PROSTATIC HYPERPLASIA TESTING REVENUE BY COUNTRIES

5.1 North America Benign Prostatic Hyperplasia Testing Revenue by Countries (2013-2018)
5.2 USA Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)

6 EUROPE BENIGN PROSTATIC HYPERPLASIA TESTING REVENUE BY COUNTRIES

6.1 Europe Benign Prostatic Hyperplasia Testing Revenue by Countries (2013-2018)
6.2 Germany Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
6.3 UK Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
6.4 France Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC BENIGN PROSTATIC HYPERPLASIA TESTING REVENUE BY COUNTRIES

7.1 Asia-Pacific Benign Prostatic Hyperplasia Testing Revenue by Countries (2013-2018)
7.2 China Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
7.5 India Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA BENIGN PROSTATIC HYPERPLASIA TESTING REVENUE BY COUNTRIES

8.1 South America Benign Prostatic Hyperplasia Testing Revenue by Countries (2013-2018)
8.2 Brazil Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE BENIGN PROSTATIC HYPERPLASIA TESTING BY COUNTRIES

9.1 Middle East and Africa Benign Prostatic Hyperplasia Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)

10 GLOBAL BENIGN PROSTATIC HYPERPLASIA TESTING MARKET SEGMENT BY TYPE

10.1 Global Benign Prostatic Hyperplasia Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Benign Prostatic Hyperplasia Testing Market Forecast by Type (2018-2023)
10.3 Urinalysis Revenue Growth Rate (2013-2023)
10.4 Prostate-Specific Antigen (PSA) Blood Test Revenue Growth Rate (2013-2023)
10.5 Urodynamic Test Revenue Growth Rate (2013-2023)
10.6 Cystoscopy Revenue Growth Rate (2013-2023)

11 GLOBAL BENIGN PROSTATIC HYPERPLASIA TESTING MARKET SEGMENT BY APPLICATION

11.1 Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Application (2013-2018)
11.2 Benign Prostatic Hyperplasia Testing Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Diagnostic Centers Revenue Growth (2013-2018)
11.5 Clinics Revenue Growth (2013-2018)
11.6 Research Institutes Revenue Growth (2013-2018)

12 GLOBAL BENIGN PROSTATIC HYPERPLASIA TESTING MARKET SIZE FORECAST (2018-2023)

12.1 Global Benign Prostatic Hyperplasia Testing Market Size Forecast (2018-2023)
12.2 Global Benign Prostatic Hyperplasia Testing Market Forecast by Regions (2018-2023)
12.3 North America Benign Prostatic Hyperplasia Testing Revenue Market Forecast (2018-2023)
12.4 Europe Benign Prostatic Hyperplasia Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Benign Prostatic Hyperplasia Testing Revenue Market Forecast (2018-2023)
12.6 South America Benign Prostatic Hyperplasia Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Benign Prostatic Hyperplasia Testing Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Benign Prostatic Hyperplasia Testing Picture
Table Product Specifications of Benign Prostatic Hyperplasia Testing
Table Global Benign Prostatic Hyperplasia Testing and Revenue (Million USD) Market Split by Product Type
Figure Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Types in 2017
Figure Urinalysis Picture
Figure Prostate-Specific Antigen (PSA) Blood Test Picture
Figure Urodynamic Test Picture
Figure Cystoscopy Picture
Table Global Benign Prostatic Hyperplasia Testing Revenue (Million USD) by Application (2013-2023)
Figure Benign Prostatic Hyperplasia Testing Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Diagnostic Centers Picture
Figure Clinics Picture
Figure Research Institutes Picture
Table Global Market Benign Prostatic Hyperplasia Testing Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Benign Prostatic Hyperplasia Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Benign Prostatic Hyperplasia Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Benign Prostatic Hyperplasia Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Benign Prostatic Hyperplasia Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Benign Prostatic Hyperplasia Testing Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Benign Prostatic Hyperplasia Testing Revenue (Million USD) and Growth Rate (2013-2023)
Table AEternaZentaris Basic Information, Manufacturing Base and Competitors
Table AEternaZentaris Benign Prostatic Hyperplasia Testing Type and Applications
Table AEternaZentaris Benign Prostatic Hyperplasia Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Benign Prostatic Hyperplasia Testing Type and Applications
Table Astellas Pharma Benign Prostatic Hyperplasia Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Company Benign Prostatic Hyperplasia Testing Type and Applications
Table Eli Lilly and Company Benign Prostatic Hyperplasia Testing Revenue, Gross Margin and Market Share (2016-2017)
Table IntelGenx Technologies Corp Basic Information, Manufacturing Base and Competitors
Table IntelGenx Technologies Corp Benign Prostatic Hyperplasia Testing Type and Applications
Table IntelGenx Technologies Corp Benign Prostatic Hyperplasia Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Nymox Pharmaceutical Corporation Basic Information, Manufacturing Base and Competitors
Table Nymox Pharmaceutical Corporation Benign Prostatic Hyperplasia Testing Type and Applications
Table Nymox Pharmaceutical Corporation Benign Prostatic Hyperplasia Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Protox Therapeutics Basic Information, Manufacturing Base and Competitors
Table Protox Therapeutics Benign Prostatic Hyperplasia Testing Type and Applications
Table Protox Therapeutics Benign Prostatic Hyperplasia Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Quest PharmaTech Basic Information, Manufacturing Base and Competitors
Table Quest PharmaTech Benign Prostatic Hyperplasia Testing Type and Applications
Table Quest PharmaTech Benign Prostatic Hyperplasia Testing Revenue, Gross Margin and Market Share (2016-2017)
Table Global Benign Prostatic Hyperplasia Testing Revenue (Million USD) by Players (2013-2018)
Table Global Benign Prostatic Hyperplasia Testing Revenue Share by Players (2013-2018)
Figure Global Benign Prostatic Hyperplasia Testing Revenue Share by Players in 2016
Figure Global Benign Prostatic Hyperplasia Testing Revenue Share by Players in 2017
Figure Global Top 5 Players Benign Prostatic Hyperplasia Testing Revenue Market Share in 2017
Figure Global Top 10 Players Benign Prostatic Hyperplasia Testing Revenue Market Share in 2017
Figure Global Benign Prostatic Hyperplasia Testing Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Benign Prostatic Hyperplasia Testing Revenue (Million USD) by Regions (2013-2018)
Table Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Regions (2013-2018)
Figure Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Regions (2013-2018)
Figure Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Regions in 2017
Figure North America Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure Europe Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure South America Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Table North America Benign Prostatic Hyperplasia Testing Revenue by Countries (2013-2018)
Table North America Benign Prostatic Hyperplasia Testing Revenue Market Share by Countries (2013-2018)
Figure North America Benign Prostatic Hyperplasia Testing Revenue Market Share by Countries (2013-2018)
Figure North America Benign Prostatic Hyperplasia Testing Revenue Market Share by Countries in 2017
Figure USA Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure Canada Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure Mexico Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Table Europe Benign Prostatic Hyperplasia Testing Revenue (Million USD) by Countries (2013-2018)
Figure Europe Benign Prostatic Hyperplasia Testing Revenue Market Share by Countries (2013-2018)
Figure Europe Benign Prostatic Hyperplasia Testing Revenue Market Share by Countries in 2017
Figure Germany Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure UK Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure France Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure Russia Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure Italy Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Benign Prostatic Hyperplasia Testing Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Benign Prostatic Hyperplasia Testing Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Benign Prostatic Hyperplasia Testing Revenue Market Share by Countries in 2017
Figure China Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure Japan Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure Korea Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure India Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Table South America Benign Prostatic Hyperplasia Testing Revenue by Countries (2013-2018)
Table South America Benign Prostatic Hyperplasia Testing Revenue Market Share by Countries (2013-2018)
Figure South America Benign Prostatic Hyperplasia Testing Revenue Market Share by Countries (2013-2018)
Figure South America Benign Prostatic Hyperplasia Testing Revenue Market Share by Countries in 2017
Figure Brazil Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure Argentina Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure Colombia Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Benign Prostatic Hyperplasia Testing Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Benign Prostatic Hyperplasia Testing Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Benign Prostatic Hyperplasia Testing Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Benign Prostatic Hyperplasia Testing Revenue Market Share by Countries in 2017
Figure Saudi Arabia Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure UAE Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure Egypt Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure Nigeria Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Figure South Africa Benign Prostatic Hyperplasia Testing Revenue and Growth Rate (2013-2018)
Table Global Benign Prostatic Hyperplasia Testing Revenue (Million USD) by Type (2013-2018)
Table Global Benign Prostatic Hyperplasia Testing Revenue Share by Type (2013-2018)
Figure Global Benign Prostatic Hyperplasia Testing Revenue Share by Type (2013-2018)
Figure Global Benign Prostatic Hyperplasia Testing Revenue Share by Type in 2017
Table Global Benign Prostatic Hyperplasia Testing Revenue Forecast by Type (2018-2023)
Figure Global Benign Prostatic Hyperplasia Testing Market Share Forecast by Type (2018-2023)
Figure Global Urinalysis Revenue Growth Rate (2013-2018)
Figure Global Prostate-Specific Antigen (PSA) Blood Test Revenue Growth Rate (2013-2018)
Figure Global Urodynamic Test Revenue Growth Rate (2013-2018)
Figure Global Cystoscopy Revenue Growth Rate (2013-2018)
Table Global Benign Prostatic Hyperplasia Testing Revenue by Application (2013-2018)
Table Global Benign Prostatic Hyperplasia Testing Revenue Share by Application (2013-2018)
Figure Global Benign Prostatic Hyperplasia Testing Revenue Share by Application (2013-2018)
Figure Global Benign Prostatic Hyperplasia Testing Revenue Share by Application in 2017
Table Global Benign Prostatic Hyperplasia Testing Revenue Forecast by Application (2018-2023)
Figure Global Benign Prostatic Hyperplasia Testing Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Diagnostic Centers Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Research Institutes Revenue Growth Rate (2013-2018)
Figure Global Benign Prostatic Hyperplasia Testing Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Benign Prostatic Hyperplasia Testing Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Benign Prostatic Hyperplasia Testing Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Benign Prostatic Hyperplasia Testing Revenue Market Forecast (2018-2023)
Figure Europe Benign Prostatic Hyperplasia Testing Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Benign Prostatic Hyperplasia Testing Revenue Market Forecast (2018-2023)
Figure South America Benign Prostatic Hyperplasia Testing Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Benign Prostatic Hyperplasia Testing Revenue Market Forecast (2018-2023)